Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
MIRM
#1212
Mirum Pharmaceuticals, Inc. Common Stock
96.900
0
USD
+0.42%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+0.42%
Changement Mensuel
+6.77%
Evolution sur 6 mois
+38.17%
Changement Annuel
+38.17%
Clôture Précédente
96.490
0
Open
96.900
0
Bid
Ask
Low
96.900
0
High
96.900
0
Volume
100
Marchés
Actions des Marchés US
Soins de Santé
MIRM
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
30.42 M
31.73 M
37.95 M
47 M
49.01 M
60.34 M
—
Valuation ratios
Enterprise value
389.04 M
474.76 M
703.69 M
1.43 B
2.12 B
4.79 B
13.58 B
Price to earnings ratio
—
—
-4.8
-7.5
-22.35
-168.06
-323.35
Price to sales ratio
—
—
8.5
6.59
5.83
7.61
26.96
Price to cash flow ratio
—
—
-5.45
-17.3
190.32
71.03
135.26
Price to book ratio
—
—
4.61
4.94
8.71
12.6
21.26
Enterprise value to EBITDA ratio
—
-2.75
-5.5
-11.44
-28.2
2 120.35
1 812.43
Profitability ratios
Return on assets %
-0.43
-0.29
-0.38
-0.25
-0.13
-0.03
-0.03
Return on equity %
-0.6
-0.7
-0.96
-0.66
-0.39
-0.07
-0.09
Return on invested capital %
-2 442.67
-1 011.75
-339.27
-200.11
-128
-33.71
-28.71
Gross margin %
—
100
100
100
100
100
400
Operating margin %
—
-906.12
-170.28
-58.57
-26
-4.25
-18.62
EBITDA margin %
—
-903.01
-166.08
-52.76
-18.99
0.4
0.18
Net margin %
—
-438.85
-176.05
-87.68
-26.1
-4.48
-19.4
Liquidity ratios
Quick ratio
—
3.88
2.85
4.19
2.93
2.55
11.73
Current ratio
12.8
3.91
2.94
4.45
3.1
2.67
12.33
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
0.07
0.24
0.37
0.51
0.69
0.7
Solvency ratios
Debt to assets ratio
—
—
—
0.48
0.47
0.38
1.68
Debt to equity ratio
—
—
—
1.24
1.41
1.02
4.72
Long term debt to total assets ratio
—
—
—
0.47
0.46
0.37
1.63
Long term debt to total equity ratio
—
—
—
1.23
1.37
0.98
4.58
Per share metrics
Operating cash flow per share
—
—
-3.54
-1.74
0.22
1.11
1.02
EBIT per share
—
—
-3.86
-2.67
-1.84
-0.44
-0.46
EBITDA per share
—
—
-3.77
-2.4
-1.35
0.04
0.02
Total debt per share
—
—
—
7.54
6.69
6.36
24.86
Cash per share
—
—
4.46
7
5.9
7.64
26.03
Net current asset value per share
—
—
5.6
9.48
8.27
10.95
37.78
Tangible book value per share
—
—
2.44
-0.1
-0.51
1.07
2.26
Working capital per share
—
—
3.69
7.35
5.6
6.85
25.35
Book value per share
—
—
4.18
6.08
4.75
6.27
21.3
Nouvelles
Cipher Mining Stock, Five Below, Indivior Among 10 New Stocks On IBD Watchlists
ASML, An AI Megatrend Star, Leads 8 Newcomers To Best Stock Lists
Cantor Fitzgerald réitère sa recommandation sur l’action Mirum Pharmaceuticals
Gold Stocks, AI Leader Broadcom Among 25 Newcomers To Best Stock Lists
Mirum Pharmaceuticals (MIRM) Moves 5.1% Higher: Will This Strength Last?
Why Is Mirum Pharmaceuticals (MIRM) Down 3.6% Since Last Earnings Report?
TD Cowen relève l’objectif de cours de Mirum Pharmaceuticals à 125$
Citizens réitère sa recommandation sur Mirum Pharmaceuticals après les données HDV
Citizens réitère sa recommandation sur Mirum Pharmaceuticals avant les données
Construction Giant MasTec Leads 11 Newcomers To Best Stock Lists, Defies Market Correction
Le directeur financier de Mirum Pharma, Bjerkholt, vend pour 670.000$ d’actions
Le président de Mirum Pharmaceuticals vend pour 1,5 million de dollars d’actions